Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety
Condition(s) studied
Investigational drug(s) / intervention(s)
MDT referral and review software: Use of the multi-disciplinary team (MDT) meeting software to submit, review and discuss referrals
Study summary
Multi-Disciplinary Team (MDT) meetings are crucial for planning patient care in the National Health Service (NHS), but they can be time-consuming and sometimes lack complete patient information. This can lead to delays in treatment decisions, potentially incomplete care plans, or the need to repeatedly discuss the same patient cases.
This study aims to test a new software called Salutare One Referral. One Referral is designed to make these meetings more efficient and effective. We want to see if this software can help healthcare staff prepare MDT referral information more easily and facilitate a more informed MDT discussion, which could lead to better patient care. If successful, this could help improve how MDTs operate across the NHS.
Eligibility
Primary outcome measure(s)
- One Referral system safety in facilitating effective MDT meetings — 8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs
MDT panel participant feedback on safety and operational incidents - One Referral system implementation feasibility in facilitating effective MDT meetings — 8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs
MDT panel participant feedback on effectiveness (non-validated questionnaire) - One Referral system acceptability to MDT panel members acceptability in facilitating — 8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs
MDT panel participant feedback on acceptability (Software Usability Scale 0-100, higher score indicate a better outcome)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Royal National Orthopaedic Hospital | London | United Kingdom | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07104955 on ClinicalTrials.gov ↗ ← All trials in the UK